ADD luminex panel table
This commit is contained in:
parent
c30b7d3c2d
commit
043087ddc5
|
@ -0,0 +1,38 @@
|
|||
\begin{tabular}{lrr}
|
||||
\hline
|
||||
Cytokine & Dilution Factor & Panel Number\\
|
||||
\hline
|
||||
APRIL & 1 & 1\\
|
||||
BAFF & 1 & 1\\
|
||||
GM-CSF & 1 & 1\\
|
||||
IFF$\upalpha$ & 1 & 1\\
|
||||
IFN$\upgamma$ & 1 & 1\\
|
||||
IL10 & 1 & 1\\
|
||||
IL12p70 & 1 & 1\\
|
||||
IL15 & 1 & 1\\
|
||||
IL16 & 1 & 1\\
|
||||
IL17a & 1 & 1\\
|
||||
IL2 & 1 & 1\\
|
||||
IL21 & 1 & 1\\
|
||||
IL23 & 1 & 1\\
|
||||
IL3 & 1 & 1\\
|
||||
IL31 & 1 & 1\\
|
||||
IL4 & 1 & 1\\
|
||||
IL5 & 1 & 1\\
|
||||
IL6 & 1 & 1\\
|
||||
IL9 & 1 & 1\\
|
||||
LIF & 1 & 1\\
|
||||
MCP-1 & 1 & 1\\
|
||||
MIF & 1 & 1\\
|
||||
OSM & 1 & 1\\
|
||||
TNF$\upalpha$ & 1 & 1\\
|
||||
TNF$\upbeta$ & 1 & 1\\
|
||||
IL13 & 1 & 1\\
|
||||
IL2R & 1 & 1\\
|
||||
IL8 & 1 & 1\\
|
||||
MIP-1$\upalpha$ & 10 & 2\\
|
||||
MIP-1$\upbeta$ & 10 & 2\\
|
||||
RANTES & 10 & 2\\
|
||||
TGF$\upbeta$ & 1 & 3\\
|
||||
\hline
|
||||
\end{tabular}
|
|
@ -930,6 +930,16 @@ plates and incubated for another \SI{24}{\hour}. Cells and beads/\glspl{dms}
|
|||
were removed from the retronectin plates using vigorous pipetting and
|
||||
transferred to another 96 well plate wherein expansion continued.
|
||||
|
||||
\subsection{Luminex}
|
||||
|
||||
% METHOD luminex
|
||||
|
||||
\begin{table}[!h] \centering
|
||||
\caption{Luminex Panel}
|
||||
\label{tab:luminex_panel}
|
||||
\input{../tables/luminex_panel.tex}
|
||||
\end{table}
|
||||
|
||||
\subsection{statistical analysis}
|
||||
|
||||
For 1-way \gls{anova} analysis with Tukey multiple comparisons test,
|
||||
|
@ -1669,8 +1679,6 @@ provide these benefits.
|
|||
|
||||
\subsection{DOE shows optimal conditions for expanded potent T cells}
|
||||
|
||||
% TABLE luminex panel used
|
||||
|
||||
% TODO this plots proportions look dumb
|
||||
\begin{figure*}[ht!]
|
||||
\begingroup
|
||||
|
|
Loading…
Reference in New Issue